Designed for diagnostic manufactures and laboratories of all sizes, this two-day executive level meeting will provide participants with extensive, in-depth learning and knowledge share. Through case study driven presentations, high level keynote sessions as well as round table panel discussions complemented by multiple networking opportunities, the program will foster a sense of collaboration. Building upon the many successful Q1 reimbursement focused conferences of the past several years, this meeting promises to be an enlightening and valuable program for diagnostic reimbursement professionals.

Topics To Be Addressed

Ramifications of Medicaid expansion on diagnostic reimbursement

Commercial payer insight and policy on establishing clinical utility

Myriad Case Study: Clinical Utility Studies to Support Potential Payer Coverage

Working with MACs to leverage local and national coverage decisions for diagnostics

ACO roundtable: Inside the standards used to make decisions

PAMA update: Preparation for laboratory reporting requirements

MoPath codes for next-generation sequencing (NGS) technologies

Walking through a health technology assessment: Guidance & establishing value

Building economic models to demonstrate prevalence in an era of personalized medicine

Panel discussion: Obtaining evidence to demonstrate clinical utility & secure coverage

Case study: Increasing the value proposition of companion diagnostics to further integration

Diagnostic pricing strategies in light of payment reform

Demonstration of diagnostic product differentiation

Addressing reimbursement denials: Opportunities & next steps

Pathways for demonstrating value and cost effectiveness to payers on a global scale